Henry Schein (HSIC) Competitors

$74.21 0.00 (0.00%)

Closing price 05/22/2026 04:00 PM Eastern

Extended Trading

$74.20 0.00 (-0.01%)

As of 05/22/2026 04:20 PM Eastern

HSIC vs. COO, IDXX, MASI, MMSI, and AMN

Should you buy Henry Schein stock or one of its competitors? MarketBeat compares Henry Schein with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Henry Schein include Cooper Companies (COO), IDEXX Laboratories (IDXX), Masimo (MASI), Merit Medical Systems (MMSI), and AMN Healthcare Services (AMN). These companies are all part of the "medical" sector.

How does Henry Schein compare to Cooper Companies?

Henry Schein (NASDAQ:HSIC) and Cooper Companies (NASDAQ:COO) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.

Cooper Companies has a net margin of 9.67% compared to Henry Schein's net margin of 2.95%. Henry Schein's return on equity of 15.44% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.95%	15.44%	5.53%
Cooper Companies	9.67%	10.34%	6.93%

Henry Schein currently has a consensus price target of $86.83, suggesting a potential upside of 17.01%. Cooper Companies has a consensus price target of $90.79, suggesting a potential upside of 45.14%. Given Cooper Companies' stronger consensus rating and higher probable upside, analysts plainly believe Cooper Companies is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36
Cooper Companies	1 Sell rating(s)	7 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.53

Henry Schein has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market.

In the previous week, Cooper Companies had 1 more articles in the media than Henry Schein. MarketBeat recorded 7 mentions for Cooper Companies and 6 mentions for Henry Schein. Cooper Companies' average media sentiment score of 0.89 beat Henry Schein's score of 0.71 indicating that Cooper Companies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cooper Companies	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by company insiders. Comparatively, 2.1% of Cooper Companies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Henry Schein has higher revenue and earnings than Cooper Companies. Henry Schein is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.64	$398M	$3.31	22.42
Cooper Companies	$4.09B	2.98	$374.90M	$2.02	30.97

Summary

Cooper Companies beats Henry Schein on 12 of the 17 factors compared between the two stocks.

How does Henry Schein compare to IDEXX Laboratories?

IDEXX Laboratories (NASDAQ:IDXX) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability and risk.

IDEXX Laboratories has higher earnings, but lower revenue than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	10.25	$1.06B	$13.58	41.19
Henry Schein	$13.18B	0.64	$398M	$3.31	22.42

IDEXX Laboratories has a net margin of 24.63% compared to Henry Schein's net margin of 2.95%. IDEXX Laboratories' return on equity of 70.87% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	24.63%	70.87%	32.56%
Henry Schein	2.95%	15.44%	5.53%

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 0.8% of IDEXX Laboratories shares are owned by insiders. Comparatively, 0.9% of Henry Schein shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

IDEXX Laboratories has a beta of 1.58, meaning that its stock price is 58% more volatile than the broader market. Comparatively, Henry Schein has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market.

In the previous week, IDEXX Laboratories had 13 more articles in the media than Henry Schein. MarketBeat recorded 19 mentions for IDEXX Laboratories and 6 mentions for Henry Schein. IDEXX Laboratories' average media sentiment score of 1.48 beat Henry Schein's score of 0.71 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	17 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

IDEXX Laboratories currently has a consensus target price of $751.00, indicating a potential upside of 34.26%. Henry Schein has a consensus target price of $86.83, indicating a potential upside of 17.01%. Given IDEXX Laboratories' stronger consensus rating and higher possible upside, equities research analysts plainly believe IDEXX Laboratories is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.64
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36

Summary

IDEXX Laboratories beats Henry Schein on 13 of the 16 factors compared between the two stocks.

How does Henry Schein compare to Masimo?

Masimo (NASDAQ:MASI) and Henry Schein (NASDAQ:HSIC) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, earnings, valuation and risk.

Henry Schein has higher revenue and earnings than Masimo. Masimo is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Masimo	$1.53B	6.13	-$151.50M	-$10.54	N/A
Henry Schein	$13.18B	0.64	$398M	$3.31	22.42

Masimo has a net margin of 4.90% compared to Henry Schein's net margin of 2.95%. Masimo's return on equity of 31.33% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Masimo	4.90%	31.33%	13.93%
Henry Schein	2.95%	15.44%	5.53%

In the previous week, Henry Schein had 4 more articles in the media than Masimo. MarketBeat recorded 6 mentions for Henry Schein and 2 mentions for Masimo. Henry Schein's average media sentiment score of 0.71 beat Masimo's score of -0.14 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Masimo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Henry Schein	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Masimo currently has a consensus price target of $180.40, indicating a potential upside of 0.89%. Henry Schein has a consensus price target of $86.83, indicating a potential upside of 17.01%. Given Henry Schein's stronger consensus rating and higher probable upside, analysts clearly believe Henry Schein is more favorable than Masimo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Masimo	0 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36

Masimo has a beta of 1.13, meaning that its stock price is 13% more volatile than the broader market. Comparatively, Henry Schein has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market.

86.0% of Masimo shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 9.7% of Masimo shares are owned by company insiders. Comparatively, 0.9% of Henry Schein shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Henry Schein beats Masimo on 10 of the 16 factors compared between the two stocks.

How does Henry Schein compare to Merit Medical Systems?

Henry Schein (NASDAQ:HSIC) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings and risk.

Henry Schein currently has a consensus price target of $86.83, indicating a potential upside of 17.01%. Merit Medical Systems has a consensus price target of $92.80, indicating a potential upside of 44.62%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe Merit Medical Systems is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64

Henry Schein has higher revenue and earnings than Merit Medical Systems. Henry Schein is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.64	$398M	$3.31	22.42
Merit Medical Systems	$1.52B	2.53	$128.49M	$2.31	27.78

Merit Medical Systems has a net margin of 9.03% compared to Henry Schein's net margin of 2.95%. Henry Schein's return on equity of 15.44% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.95%	15.44%	5.53%
Merit Medical Systems	9.03%	13.54%	7.94%

Henry Schein has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market.

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 0.9% of Henry Schein shares are held by insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Merit Medical Systems had 6 more articles in the media than Henry Schein. MarketBeat recorded 12 mentions for Merit Medical Systems and 6 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.71 beat Merit Medical Systems' score of 0.60 indicating that Henry Schein is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Merit Medical Systems beats Henry Schein on 9 of the 16 factors compared between the two stocks.

How does Henry Schein compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings and valuation.

Henry Schein has a net margin of 2.95% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-0.95%	18.01%	5.19%
Henry Schein	2.95%	15.44%	5.53%

In the previous week, Henry Schein had 3 more articles in the media than AMN Healthcare Services. MarketBeat recorded 6 mentions for Henry Schein and 3 mentions for AMN Healthcare Services. Henry Schein's average media sentiment score of 0.71 beat AMN Healthcare Services' score of -0.25 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Henry Schein	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AMN Healthcare Services has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.82, suggesting that its stock price is 18% less volatile than the broader market.

Henry Schein has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.39	-$95.70M	-$0.87	N/A
Henry Schein	$13.18B	0.64	$398M	$3.31	22.42

AMN Healthcare Services currently has a consensus price target of $25.29, indicating a potential downside of 8.56%. Henry Schein has a consensus price target of $86.83, indicating a potential upside of 17.01%. Given Henry Schein's stronger consensus rating and higher probable upside, analysts clearly believe Henry Schein is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 0.9% of Henry Schein shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Henry Schein beats AMN Healthcare Services on 13 of the 16 factors compared between the two stocks.

Get Henry Schein News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSIC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HSIC vs. The Competition

Export

Metric	Henry Schein	MED/DENTAL Industry	Medical Sector	NASDAQ Exchange
Market Cap	$8.45B	$15.39B	$6.45B	$12.34B
Dividend Yield	N/A	1.38%	2.76%	5.28%
P/E Ratio	22.42	17.17	17.93	22.89
Price / Sales	0.64	2.27	553.92	86.28
Price / Cash	9.54	13.16	43.49	56.67
Price / Book	2.16	3.02	10.37	7.14
Net Income	$398M	$534.24M	$3.57B	$335.98M
7 Day Performance	2.09%	1.77%	6.01%	3.56%
1 Month Performance	-4.29%	2.46%	3.52%	2.54%
1 Year Performance	3.57%	-2.53%	34.13%	35.05%

Henry Schein Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HSIC Henry Schein	3.38 of 5 stars	$74.21 flat	$86.83 +17.0%	+3.6%	$8.45B	$13.18B	22.42	25,000	Positive News
COO Cooper Companies	3.9799 of 5 stars	$60.94 +2.2%	$90.79 +49.0%	-20.7%	$11.63B	$4.09B	30.17	15,000
IDXX IDEXX Laboratories	4.1056 of 5 stars	$545.79 +3.2%	$751.00 +37.6%	+11.5%	$41.71B	$4.45B	40.19	11,000	Positive News
MASI Masimo	1.1463 of 5 stars	$178.80 +0.2%	$180.40 +0.9%	+19.1%	$9.35B	$1.56B	N/A	2,200
MMSI Merit Medical Systems	3.9811 of 5 stars	$63.64 +3.7%	$92.80 +45.8%	-32.7%	$3.66B	$1.52B	27.55	7,500	Positive News Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HSIC) was last updated on 5/25/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Henry Schein (HSIC) Competitors

HSIC vs. COO, IDXX, MASI, MMSI, and AMN

How does Henry Schein compare to Cooper Companies?

Summary

How does Henry Schein compare to IDEXX Laboratories?

Summary

How does Henry Schein compare to Masimo?

Summary

How does Henry Schein compare to Merit Medical Systems?

Summary

How does Henry Schein compare to AMN Healthcare Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSIC vs. The Competition

Henry Schein Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Henry Schein (HSIC) Competitors

HSIC vs. COO, IDXX, MASI, MMSI, and AMN

How does Henry Schein compare to Cooper Companies?

Is HSIC or COO more profitable?

Do analysts prefer HSIC or COO?

Which has more risk & volatility, HSIC or COO?

Does the media refer more to HSIC or COO?

Do insiders & institutionals have more ownership in HSIC or COO?

Which has preferable valuation & earnings, HSIC or COO?

Summary

How does Henry Schein compare to IDEXX Laboratories?

Which has stronger earnings & valuation, IDXX or HSIC?

Is IDXX or HSIC more profitable?

Do insiders & institutionals believe in IDXX or HSIC?

Which has more volatility & risk, IDXX or HSIC?

Does the media refer more to IDXX or HSIC?

Do analysts prefer IDXX or HSIC?

Summary

How does Henry Schein compare to Masimo?

Which has higher valuation and earnings, MASI or HSIC?

Is MASI or HSIC more profitable?

Does the media prefer MASI or HSIC?

Do analysts recommend MASI or HSIC?

Which has more risk & volatility, MASI or HSIC?

Do insiders and institutionals believe in MASI or HSIC?

Summary

How does Henry Schein compare to Merit Medical Systems?

Do analysts recommend HSIC or MMSI?

Which has stronger valuation & earnings, HSIC or MMSI?

Is HSIC or MMSI more profitable?

Which has more volatility and risk, HSIC or MMSI?

Do institutionals and insiders believe in HSIC or MMSI?

Does the media prefer HSIC or MMSI?

Summary

How does Henry Schein compare to AMN Healthcare Services?

Is AMN or HSIC more profitable?

Does the media refer more to AMN or HSIC?

Which has more risk & volatility, AMN or HSIC?

Which has preferable valuation and earnings, AMN or HSIC?

Do analysts recommend AMN or HSIC?

Do insiders and institutionals have more ownership in AMN or HSIC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSIC vs. The Competition

Henry Schein Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools